Medical devices, healthcare technology and the business of care
PMA SUPPLEMENT · P190002/S036

Saluda Medical Evoke SCS System

Saluda Medical Pty, Ltd. · Decision date Jan 6, 2026

FDA DECISIONP190002/S036

What did the FDA approve?

FDA records P190002/S036 as a supplement to PMA P190002, with the supplement type “Normal 180 Day Track No User Fee”. The recorded decision is approval, dated Jan 6, 2026.

FDA approval order statement

approval for a manufacturing site located at Greatbatch Medical S. De R.L. De C.V., Calle 5 Norte No. 511 Ciudad, Industrial, Tijuana, Baja California, MX 22444, FEI: 3011823740 to manufacturer the Evoke Charger
Regulatory pathway
PMA supplement
Supplement type
Normal 180 Day Track No User Fee
Clinical specialty
Neurology
Decision date
Jan 6, 2026
FDA change category
Location Change - Manufacturer/Sterilizer/Packager/Supplier

FDA source record

Regulatory record facts

Identifier
P190002/S036
Regulatory pathway
PMA supplement
Product code
LGW
Decision code
APPR
Decision date
Jan 6, 2026
Source update
Nov 9, 2026
Original record
Open FDA source record

About this medical device

FDA device category: Stimulator, spinal-cord, totally implanted for pain relief.

Product code
LGW
FDA device class
3

For the original device and its historical approval scope, see PMA P190002. Subsequent supplements may change the device or its indications.

FDA decision timeline

  1. P190002 · Original PMA

    Saluda Medical Evoke SCS System

  2. P190002/S036 received

    Application receipt date recorded by FDA.

  3. P190002/S041 · Related supplement

    Saluda Medical Evoke SCS System

  4. P190002/S045 · Related supplement

    Saluda Medical Evoke SCS System

  5. P190002/S036 · FDA decision

    Normal 180 Day Track No User Fee

  6. P190002/S049 · Related supplement

    Saluda Medical Evoke SCS System

  7. P190002/S038 · Related supplement

    Saluda Medical Evoke SCS System; Closed Loop Stimulator (CLS) (REF: 3042)

  8. P190002/S039 · Related supplement

    CAP24 Paddle Lead, Passing Elevator, Evoke CLS (REF 3042), Clarity Programming Application (CPA), and RECAP Viewer

  9. P190002/S051 · Related supplement

    Saluda Medical Evoke SCS System

  10. P190002/S052 · Related supplement

    Saluda Medical Evoke SCS System

Timeline entries are records held by MedtechLedger for P190002. View FDA’s full supplement list.

Related devices and submissions

Same PMA: P190002

Explore the linked device profile

Other records with product code LGW

A shared product code identifies a classification relationship; it does not establish clinical equivalence.

Regulatory context

A PMA supplement records a change to a device with an existing premarket approval. The supplement’s approval applies to the change described in that submission.

Read our guide to FDA clearance and approval · FDA’s explanation of this pathway

Manufacturer intelligence

Saluda Medical Pty, Ltd.

Headquarters
Not reported
Brand website
Not reported
FDA applicant address
Level 1, 407 Pacific Hwy., Atarmon, NSW 2064

Sources and methodology

FDA fields and approval-order wording are presented as source information. MedtechLedger explanations are identified separately and describe the scope of the recorded decision. Indications from an original PMA are historical unless confirmed against subsequent labeling and supplements.

How we use FDA records